Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Radio Pharmaceutical Companies

Radiopharmaceutical companies specialize in the research, development, manufacturing, and distribution of radiopharmaceuticals. Radiopharmaceuticals are radioactive compounds used in nuclear medicine for diagnostic imaging and therapeutic applications. They are essential in diagnosing and treating various medical conditions, particularly cancer and certain heart and bone diseases.

Radiopharmaceutical Key Companies*Disclaimer: List of key companies in no particular orderLatest Radiopharmaceutical Companies Update



  • October 2023: Eclipse and GE HealthCare led an oversubscribed $56 million Series A funding round for Nucleus RadioPharma, which is the first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals. Other investors included Echo Global, Fox Chase Cancer Center, Granger Management, Mayo Clinic, Mercy Health, and the University of Missouri. In order to research, manufacture, and distribute radiopharmaceuticals, Nucleus RadioPharma will use the proceeds from this round of fundraising to open various new production sites around the country, notably in Rochester, Minnesota, close to the Mayo Clinic. Nucleus RadioPharma will not only help create the future of manufacturing, but also of a new supply chain network that will help move, track, and distribute products to patients more quickly and effectively. Target molecules will be identified, remedies will be tested, regulatory approvals will be supported, and finally, medicine will be delivered to patients with the help of this network.




  • October 2023: Pluvicto (lutetium vipivotide tetraxetan) sales increased by 220 percent, and Novartis expects this trend to continue as a result of a positive data readout. This income gain was also 12% higher than the same period last year when adjusted for the impact of foreign exchange rates. Novartis has released its first quarterly financial results after severing relations with Sandoz, a generics medication business it formerly owned. If Novartis hadn't encountered supply problems that limited patient access for much of 2023, Pluvicto's sales increase would have been much more impressive.  In addition to Pluvicto, Novartis also sells the radioligand treatment Lutathera (lutetium Lu 177 dotatate), which is used to treat some types of neuroendocrine tumors. Sales of Lutathera were $159 million in the third quarter of 2023.


List of Radiopharmaceutical Key companies in the market

  • GE Healthcare

  • Lantheus Medical Imaging Inc.

  • Novartis AG

  • BWX Technologies Inc.

  • Siemens Healthineers

  • IRE ELiT

  • JSC Isotope

  • NTP Radioisotopes SOC Ltd

  • Curium

  • Australian Nuclear Science and Technology Organization (ANSTO)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.